Haemonetics Corporation announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.
BRAINTREE, Mass., Aug. 30, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.
The public may access Mr. Simon’s presentation live via webcast and subsequent replay at: https://cc.talkpoint.com/morg007/091218a_as/?entity=117_5KF5F3F.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
CONTACT
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
View original content with multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-morgan-stanleys-global-healthcare-conference-300704493.html
SOURCE Haemonetics Corporation
Company Codes: NYSE:HAE
